 | • レポートコード：MRC2Q12-19280 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、非麻薬性鎮痛薬の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に非麻薬性鎮痛薬のグローバル市場のxxx％を占める「サリチル酸」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 非麻薬性鎮痛薬の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの非麻薬性鎮痛薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 非麻薬性鎮痛薬のグローバル主要プレイヤーには、GlaxoSmithKline Consumer Healthcare、Bayer Corporation、Atnahs Pharma、Baudax Bio、Prestige Brands, Inc.、Cumberland Pharmaceuticals, Inc.、Takeda Pharmaceutical Company、Pfizer Inc.、McNeil Consumer Healthcare、Eli Lilly and Company、Sun Pharmaceutical Industries、Validus Pharmaceuticals、Novartis Consumer Health、Pacira Pharmaceuticals, Inc.、Almatica Pharma、Actavis、Arbor Pharmaceuticals, LLC、PLx Pharma Inc.、Heron Therapeutics、Assertio Therapeutics, Inc.、Zyla Life Sciences、Jazz Pharmaceuticals plcなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 非麻薬性鎮痛薬市場は、種類と用途によって区分されます。世界の非麻薬性鎮痛薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 サリチル酸、アニリン、ピラゾロン、その他 【用途別セグメント】 病院、薬局、専門医院、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 非麻薬性鎮痛薬製品概要 - 種類別市場（サリチル酸、アニリン、ピラゾロン、その他） - 用途別市場（病院、薬局、専門医院、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の非麻薬性鎮痛薬販売量予測2017-2028 - 世界の非麻薬性鎮痛薬売上予測2017-2028 - 非麻薬性鎮痛薬の地域別販売量 - 非麻薬性鎮痛薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別非麻薬性鎮痛薬販売量 - 主要メーカー別非麻薬性鎮痛薬売上 - 主要メーカー別非麻薬性鎮痛薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（サリチル酸、アニリン、ピラゾロン、その他） - 非麻薬性鎮痛薬の種類別販売量 - 非麻薬性鎮痛薬の種類別売上 - 非麻薬性鎮痛薬の種類別価格 ・用途別市場規模（病院、薬局、専門医院、その他） - 非麻薬性鎮痛薬の用途別販売量 - 非麻薬性鎮痛薬の用途別売上 - 非麻薬性鎮痛薬の用途別価格 ・北米市場 - 北米の非麻薬性鎮痛薬市場規模（種類別、用途別） - 主要国別の非麻薬性鎮痛薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの非麻薬性鎮痛薬市場規模（種類別、用途別） - 主要国別の非麻薬性鎮痛薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の非麻薬性鎮痛薬市場規模（種類別、用途別） - 主要国別の非麻薬性鎮痛薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の非麻薬性鎮痛薬市場規模（種類別、用途別） - 主要国別の非麻薬性鎮痛薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの非麻薬性鎮痛薬市場規模（種類別、用途別） - 主要国別の非麻薬性鎮痛薬市場規模（トルコ、サウジアラビア） ・企業情報 GlaxoSmithKline Consumer Healthcare、Bayer Corporation、Atnahs Pharma、Baudax Bio、Prestige Brands, Inc.、Cumberland Pharmaceuticals, Inc.、Takeda Pharmaceutical Company、Pfizer Inc.、McNeil Consumer Healthcare、Eli Lilly and Company、Sun Pharmaceutical Industries、Validus Pharmaceuticals、Novartis Consumer Health、Pacira Pharmaceuticals, Inc.、Almatica Pharma、Actavis、Arbor Pharmaceuticals, LLC、PLx Pharma Inc.、Heron Therapeutics、Assertio Therapeutics, Inc.、Zyla Life Sciences、Jazz Pharmaceuticals plc ・産業チェーン及び販売チャネル分析 - 非麻薬性鎮痛薬の産業チェーン分析 - 非麻薬性鎮痛薬の原材料 - 非麻薬性鎮痛薬の生産プロセス - 非麻薬性鎮痛薬の販売及びマーケティング - 非麻薬性鎮痛薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 非麻薬性鎮痛薬の産業動向 - 非麻薬性鎮痛薬のマーケットドライバー - 非麻薬性鎮痛薬の課題 - 非麻薬性鎮痛薬の阻害要因 ・主な調査結果 |
Nonnarcotic analgesics refer to non steroidal anti-inflammatory drugs that have nothing to do with or have little to do with central opioid receptors
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Nonnarcotic Analgesics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Nonnarcotic Analgesics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Nonnarcotic Analgesics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Nonnarcotic Analgesics include GlaxoSmithKline Consumer Healthcare, Bayer Corporation, Atnahs Pharma, Baudax Bio, Prestige Brands, Inc., Cumberland Pharmaceuticals, Inc., Takeda Pharmaceutical Company, Pfizer Inc. and McNeil Consumer Healthcare, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Nonnarcotic Analgesics manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Nonnarcotic Analgesics market. Further, it explains the major drivers and regional dynamics of the global Nonnarcotic Analgesics market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
GlaxoSmithKline Consumer Healthcare
Bayer Corporation
Atnahs Pharma
Baudax Bio
Prestige Brands, Inc.
Cumberland Pharmaceuticals, Inc.
Takeda Pharmaceutical Company
Pfizer Inc.
McNeil Consumer Healthcare
Eli Lilly and Company
Sun Pharmaceutical Industries
Validus Pharmaceuticals
Novartis Consumer Health
Pacira Pharmaceuticals, Inc.
Almatica Pharma
Actavis
Arbor Pharmaceuticals, LLC
PLx Pharma Inc.
Heron Therapeutics
Assertio Therapeutics, Inc.
Zyla Life Sciences
Jazz Pharmaceuticals plc
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Nonnarcotic Analgesics Segment by Type
Salicylates
Anilines
Pyrazolones
Other Organic Acids
Nonnarcotic Analgesics Segment by Application
Hospital
Pharmacy
Specialist Clinic
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nonnarcotic Analgesics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Nonnarcotic Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Nonnarcotic Analgesics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Nonnarcotic Analgesics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nonnarcotic Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Nonnarcotic Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Nonnarcotic Analgesics sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GlaxoSmithKline Consumer Healthcare, Bayer Corporation, Atnahs Pharma, Baudax Bio, Prestige Brands, Inc., Cumberland Pharmaceuticals, Inc., Takeda Pharmaceutical Company, Pfizer Inc. and McNeil Consumer Healthcare, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Nonnarcotic Analgesics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Nonnarcotic Analgesics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nonnarcotic Analgesics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Nonnarcotic Analgesics Product Introduction
1.2 Market by Type
1.2.1 Global Nonnarcotic Analgesics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Salicylates
1.2.3 Anilines
1.2.4 Pyrazolones
1.2.5 Other Organic Acids
1.3 Market by Application
1.3.1 Global Nonnarcotic Analgesics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Specialist Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nonnarcotic Analgesics Sales Estimates and Forecasts 2017-2028
2.2 Global Nonnarcotic Analgesics Revenue Estimates and Forecasts 2017-2028
2.3 Global Nonnarcotic Analgesics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nonnarcotic Analgesics Sales by Region
2.4.1 Global Nonnarcotic Analgesics Sales by Region (2017-2022)
2.4.2 Global Sales Nonnarcotic Analgesics by Region (2023-2028)
2.5 Global Nonnarcotic Analgesics Revenue by Region
2.5.1 Global Nonnarcotic Analgesics Revenue by Region (2017-2022)
2.5.2 Global Nonnarcotic Analgesics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nonnarcotic Analgesics Sales by Manufacturers
3.1.1 Global Top Nonnarcotic Analgesics Manufacturers by Sales (2017-2022)
3.1.2 Global Nonnarcotic Analgesics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nonnarcotic Analgesics in 2021
3.2 Global Nonnarcotic Analgesics Revenue by Manufacturers
3.2.1 Global Nonnarcotic Analgesics Revenue by Manufacturers (2017-2022)
3.2.2 Global Nonnarcotic Analgesics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nonnarcotic Analgesics Revenue in 2021
3.3 Global Nonnarcotic Analgesics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nonnarcotic Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nonnarcotic Analgesics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nonnarcotic Analgesics Sales by Type
4.1.1 Global Nonnarcotic Analgesics Historical Sales by Type (2017-2022)
4.1.2 Global Nonnarcotic Analgesics Forecasted Sales by Type (2023-2028)
4.1.3 Global Nonnarcotic Analgesics Sales Market Share by Type (2017-2028)
4.2 Global Nonnarcotic Analgesics Revenue by Type
4.2.1 Global Nonnarcotic Analgesics Historical Revenue by Type (2017-2022)
4.2.2 Global Nonnarcotic Analgesics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nonnarcotic Analgesics Revenue Market Share by Type (2017-2028)
4.3 Global Nonnarcotic Analgesics Price by Type
4.3.1 Global Nonnarcotic Analgesics Price by Type (2017-2022)
4.3.2 Global Nonnarcotic Analgesics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nonnarcotic Analgesics Sales by Application
5.1.1 Global Nonnarcotic Analgesics Historical Sales by Application (2017-2022)
5.1.2 Global Nonnarcotic Analgesics Forecasted Sales by Application (2023-2028)
5.1.3 Global Nonnarcotic Analgesics Sales Market Share by Application (2017-2028)
5.2 Global Nonnarcotic Analgesics Revenue by Application
5.2.1 Global Nonnarcotic Analgesics Historical Revenue by Application (2017-2022)
5.2.2 Global Nonnarcotic Analgesics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nonnarcotic Analgesics Revenue Market Share by Application (2017-2028)
5.3 Global Nonnarcotic Analgesics Price by Application
5.3.1 Global Nonnarcotic Analgesics Price by Application (2017-2022)
5.3.2 Global Nonnarcotic Analgesics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nonnarcotic Analgesics Market Size by Type
6.1.1 North America Nonnarcotic Analgesics Sales by Type (2017-2028)
6.1.2 North America Nonnarcotic Analgesics Revenue by Type (2017-2028)
6.2 North America Nonnarcotic Analgesics Market Size by Application
6.2.1 North America Nonnarcotic Analgesics Sales by Application (2017-2028)
6.2.2 North America Nonnarcotic Analgesics Revenue by Application (2017-2028)
6.3 North America Nonnarcotic Analgesics Market Size by Country
6.3.1 North America Nonnarcotic Analgesics Sales by Country (2017-2028)
6.3.2 North America Nonnarcotic Analgesics Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Nonnarcotic Analgesics Market Size by Type
7.1.1 Europe Nonnarcotic Analgesics Sales by Type (2017-2028)
7.1.2 Europe Nonnarcotic Analgesics Revenue by Type (2017-2028)
7.2 Europe Nonnarcotic Analgesics Market Size by Application
7.2.1 Europe Nonnarcotic Analgesics Sales by Application (2017-2028)
7.2.2 Europe Nonnarcotic Analgesics Revenue by Application (2017-2028)
7.3 Europe Nonnarcotic Analgesics Market Size by Country
7.3.1 Europe Nonnarcotic Analgesics Sales by Country (2017-2028)
7.3.2 Europe Nonnarcotic Analgesics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nonnarcotic Analgesics Market Size by Type
8.1.1 Asia Pacific Nonnarcotic Analgesics Sales by Type (2017-2028)
8.1.2 Asia Pacific Nonnarcotic Analgesics Revenue by Type (2017-2028)
8.2 Asia Pacific Nonnarcotic Analgesics Market Size by Application
8.2.1 Asia Pacific Nonnarcotic Analgesics Sales by Application (2017-2028)
8.2.2 Asia Pacific Nonnarcotic Analgesics Revenue by Application (2017-2028)
8.3 Asia Pacific Nonnarcotic Analgesics Market Size by Region
8.3.1 Asia Pacific Nonnarcotic Analgesics Sales by Region (2017-2028)
8.3.2 Asia Pacific Nonnarcotic Analgesics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Nonnarcotic Analgesics Market Size by Type
9.1.1 Latin America Nonnarcotic Analgesics Sales by Type (2017-2028)
9.1.2 Latin America Nonnarcotic Analgesics Revenue by Type (2017-2028)
9.2 Latin America Nonnarcotic Analgesics Market Size by Application
9.2.1 Latin America Nonnarcotic Analgesics Sales by Application (2017-2028)
9.2.2 Latin America Nonnarcotic Analgesics Revenue by Application (2017-2028)
9.3 Latin America Nonnarcotic Analgesics Market Size by Country
9.3.1 Latin America Nonnarcotic Analgesics Sales by Country (2017-2028)
9.3.2 Latin America Nonnarcotic Analgesics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Nonnarcotic Analgesics Market Size by Type
10.1.1 Middle East and Africa Nonnarcotic Analgesics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nonnarcotic Analgesics Revenue by Type (2017-2028)
10.2 Middle East and Africa Nonnarcotic Analgesics Market Size by Application
10.2.1 Middle East and Africa Nonnarcotic Analgesics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nonnarcotic Analgesics Revenue by Application (2017-2028)
10.3 Middle East and Africa Nonnarcotic Analgesics Market Size by Country
10.3.1 Middle East and Africa Nonnarcotic Analgesics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nonnarcotic Analgesics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline Consumer Healthcare
11.1.1 GlaxoSmithKline Consumer Healthcare Corporation Information
11.1.2 GlaxoSmithKline Consumer Healthcare Overview
11.1.3 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Consumer Healthcare Recent Developments
11.2 Bayer Corporation
11.2.1 Bayer Corporation Corporation Information
11.2.2 Bayer Corporation Overview
11.2.3 Bayer Corporation Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Corporation Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Corporation Recent Developments
11.3 Atnahs Pharma
11.3.1 Atnahs Pharma Corporation Information
11.3.2 Atnahs Pharma Overview
11.3.3 Atnahs Pharma Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Atnahs Pharma Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Atnahs Pharma Recent Developments
11.4 Baudax Bio
11.4.1 Baudax Bio Corporation Information
11.4.2 Baudax Bio Overview
11.4.3 Baudax Bio Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Baudax Bio Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baudax Bio Recent Developments
11.5 Prestige Brands, Inc.
11.5.1 Prestige Brands, Inc. Corporation Information
11.5.2 Prestige Brands, Inc. Overview
11.5.3 Prestige Brands, Inc. Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Prestige Brands, Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Prestige Brands, Inc. Recent Developments
11.6 Cumberland Pharmaceuticals, Inc.
11.6.1 Cumberland Pharmaceuticals, Inc. Corporation Information
11.6.2 Cumberland Pharmaceuticals, Inc. Overview
11.6.3 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cumberland Pharmaceuticals, Inc. Recent Developments
11.7 Takeda Pharmaceutical Company
11.7.1 Takeda Pharmaceutical Company Corporation Information
11.7.2 Takeda Pharmaceutical Company Overview
11.7.3 Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Takeda Pharmaceutical Company Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Takeda Pharmaceutical Company Recent Developments
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Corporation Information
11.8.2 Pfizer Inc. Overview
11.8.3 Pfizer Inc. Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Inc. Recent Developments
11.9 McNeil Consumer Healthcare
11.9.1 McNeil Consumer Healthcare Corporation Information
11.9.2 McNeil Consumer Healthcare Overview
11.9.3 McNeil Consumer Healthcare Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 McNeil Consumer Healthcare Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 McNeil Consumer Healthcare Recent Developments
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Corporation Information
11.10.2 Eli Lilly and Company Overview
11.10.3 Eli Lilly and Company Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Eli Lilly and Company Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Eli Lilly and Company Recent Developments
11.11 Sun Pharmaceutical Industries
11.11.1 Sun Pharmaceutical Industries Corporation Information
11.11.2 Sun Pharmaceutical Industries Overview
11.11.3 Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sun Pharmaceutical Industries Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sun Pharmaceutical Industries Recent Developments
11.12 Validus Pharmaceuticals
11.12.1 Validus Pharmaceuticals Corporation Information
11.12.2 Validus Pharmaceuticals Overview
11.12.3 Validus Pharmaceuticals Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Validus Pharmaceuticals Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Validus Pharmaceuticals Recent Developments
11.13 Novartis Consumer Health
11.13.1 Novartis Consumer Health Corporation Information
11.13.2 Novartis Consumer Health Overview
11.13.3 Novartis Consumer Health Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Novartis Consumer Health Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Novartis Consumer Health Recent Developments
11.14 Pacira Pharmaceuticals, Inc.
11.14.1 Pacira Pharmaceuticals, Inc. Corporation Information
11.14.2 Pacira Pharmaceuticals, Inc. Overview
11.14.3 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pacira Pharmaceuticals, Inc. Recent Developments
11.15 Almatica Pharma
11.15.1 Almatica Pharma Corporation Information
11.15.2 Almatica Pharma Overview
11.15.3 Almatica Pharma Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Almatica Pharma Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Almatica Pharma Recent Developments
11.16 Actavis
11.16.1 Actavis Corporation Information
11.16.2 Actavis Overview
11.16.3 Actavis Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Actavis Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Actavis Recent Developments
11.17 Arbor Pharmaceuticals, LLC
11.17.1 Arbor Pharmaceuticals, LLC Corporation Information
11.17.2 Arbor Pharmaceuticals, LLC Overview
11.17.3 Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Arbor Pharmaceuticals, LLC Recent Developments
11.18 PLx Pharma Inc.
11.18.1 PLx Pharma Inc. Corporation Information
11.18.2 PLx Pharma Inc. Overview
11.18.3 PLx Pharma Inc. Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 PLx Pharma Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 PLx Pharma Inc. Recent Developments
11.19 Heron Therapeutics
11.19.1 Heron Therapeutics Corporation Information
11.19.2 Heron Therapeutics Overview
11.19.3 Heron Therapeutics Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Heron Therapeutics Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Heron Therapeutics Recent Developments
11.20 Assertio Therapeutics, Inc.
11.20.1 Assertio Therapeutics, Inc. Corporation Information
11.20.2 Assertio Therapeutics, Inc. Overview
11.20.3 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Assertio Therapeutics, Inc. Recent Developments
11.21 Zyla Life Sciences
11.21.1 Zyla Life Sciences Corporation Information
11.21.2 Zyla Life Sciences Overview
11.21.3 Zyla Life Sciences Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Zyla Life Sciences Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Zyla Life Sciences Recent Developments
11.22 Jazz Pharmaceuticals plc
11.22.1 Jazz Pharmaceuticals plc Corporation Information
11.22.2 Jazz Pharmaceuticals plc Overview
11.22.3 Jazz Pharmaceuticals plc Nonnarcotic Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Jazz Pharmaceuticals plc Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Jazz Pharmaceuticals plc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nonnarcotic Analgesics Industry Chain Analysis
12.2 Nonnarcotic Analgesics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nonnarcotic Analgesics Production Mode & Process
12.4 Nonnarcotic Analgesics Sales and Marketing
12.4.1 Nonnarcotic Analgesics Sales Channels
12.4.2 Nonnarcotic Analgesics Distributors
12.5 Nonnarcotic Analgesics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nonnarcotic Analgesics Industry Trends
13.2 Nonnarcotic Analgesics Market Drivers
13.3 Nonnarcotic Analgesics Market Challenges
13.4 Nonnarcotic Analgesics Market Restraints
14 Key Findings in The Global Nonnarcotic Analgesics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Nonnarcotic Analgesics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Salicylates
Table 3. Major Manufacturers of Anilines
Table 4. Major Manufacturers of Pyrazolones
Table 5. Major Manufacturers of Other Organic Acids
Table 6. Global Nonnarcotic Analgesics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Nonnarcotic Analgesics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Nonnarcotic Analgesics Sales by Region (2017-2022) & (K Units)
Table 9. Global Nonnarcotic Analgesics Sales Market Share by Region (2017-2022)
Table 10. Global Nonnarcotic Analgesics Sales by Region (2023-2028) & (K Units)
Table 11. Global Nonnarcotic Analgesics Sales Market Share by Region (2023-2028)
Table 12. Global Nonnarcotic Analgesics Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Nonnarcotic Analgesics Revenue Market Share by Region (2017-2022)
Table 14. Global Nonnarcotic Analgesics Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Nonnarcotic Analgesics Revenue Market Share by Region (2023-2028)
Table 16. Global Nonnarcotic Analgesics Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Nonnarcotic Analgesics Sales Share by Manufacturers (2017-2022)
Table 18. Global Nonnarcotic Analgesics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Nonnarcotic Analgesics Revenue Share by Manufacturers (2017-2022)
Table 20. Nonnarcotic Analgesics Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Nonnarcotic Analgesics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Nonnarcotic Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonnarcotic Analgesics as of 2021)
Table 23. Nonnarcotic Analgesics Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Nonnarcotic Analgesics Product Offered
Table 25. Date of Manufacturers Enter into Nonnarcotic Analgesics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nonnarcotic Analgesics Sales by Type (2017-2022) & (K Units)
Table 28. Global Nonnarcotic Analgesics Sales by Type (2023-2028) & (K Units)
Table 29. Global Nonnarcotic Analgesics Sales Share by Type (2017-2022)
Table 30. Global Nonnarcotic Analgesics Sales Share by Type (2023-2028)
Table 31. Global Nonnarcotic Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Nonnarcotic Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Nonnarcotic Analgesics Revenue Share by Type (2017-2022)
Table 34. Global Nonnarcotic Analgesics Revenue Share by Type (2023-2028)
Table 35. Nonnarcotic Analgesics Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Nonnarcotic Analgesics Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Nonnarcotic Analgesics Sales by Application (2017-2022) & (K Units)
Table 38. Global Nonnarcotic Analgesics Sales by Application (2023-2028) & (K Units)
Table 39. Global Nonnarcotic Analgesics Sales Share by Application (2017-2022)
Table 40. Global Nonnarcotic Analgesics Sales Share by Application (2023-2028)
Table 41. Global Nonnarcotic Analgesics Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Nonnarcotic Analgesics Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Nonnarcotic Analgesics Revenue Share by Application (2017-2022)
Table 44. Global Nonnarcotic Analgesics Revenue Share by Application (2023-2028)
Table 45. Nonnarcotic Analgesics Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Nonnarcotic Analgesics Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Nonnarcotic Analgesics Sales by Type (2017-2022) & (K Units)
Table 48. North America Nonnarcotic Analgesics Sales by Type (2023-2028) & (K Units)
Table 49. North America Nonnarcotic Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Nonnarcotic Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Nonnarcotic Analgesics Sales by Application (2017-2022) & (K Units)
Table 52. North America Nonnarcotic Analgesics Sales by Application (2023-2028) & (K Units)
Table 53. North America Nonnarcotic Analgesics Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Nonnarcotic Analgesics Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Nonnarcotic Analgesics Sales by Country (2017-2022) & (K Units)
Table 56. North America Nonnarcotic Analgesics Sales by Country (2023-2028) & (K Units)
Table 57. North America Nonnarcotic Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Nonnarcotic Analgesics Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Nonnarcotic Analgesics Sales by Type (2017-2022) & (K Units)
Table 60. Europe Nonnarcotic Analgesics Sales by Type (2023-2028) & (K Units)
Table 61. Europe Nonnarcotic Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Nonnarcotic Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Nonnarcotic Analgesics Sales by Application (2017-2022) & (K Units)
Table 64. Europe Nonnarcotic Analgesics Sales by Application (2023-2028) & (K Units)
Table 65. Europe Nonnarcotic Analgesics Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Nonnarcotic Analgesics Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Nonnarcotic Analgesics Sales by Country (2017-2022) & (K Units)
Table 68. Europe Nonnarcotic Analgesics Sales by Country (2023-2028) & (K Units)
Table 69. Europe Nonnarcotic Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Nonnarcotic Analgesics Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Nonnarcotic Analgesics Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Nonnarcotic Analgesics Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Nonnarcotic Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Nonnarcotic Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Nonnarcotic Analgesics Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Nonnarcotic Analgesics Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Nonnarcotic Analgesics Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Nonnarcotic Analgesics Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Nonnarcotic Analgesics Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Nonnarcotic Analgesics Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Nonnarcotic Analgesics Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Nonnarcotic Analgesics Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Nonnarcotic Analgesics Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Nonnarcotic Analgesics Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Nonnarcotic Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Nonnarcotic Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Nonnarcotic Analgesics Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Nonnarcotic Analgesics Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Nonnarcotic Analgesics Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Nonnarcotic Analgesics Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Nonnarcotic Analgesics Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Nonnarcotic Analgesics Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Nonnarcotic Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Nonnarcotic Analgesics Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Nonnarcotic Analgesics Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Nonnarcotic Analgesics Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Nonnarcotic Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Nonnarcotic Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Nonnarcotic Analgesics Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Nonnarcotic Analgesics Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Nonnarcotic Analgesics Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Nonnarcotic Analgesics Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Nonnarcotic Analgesics Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Nonnarcotic Analgesics Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Nonnarcotic Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Nonnarcotic Analgesics Revenue by Country (2023-2028) & (US$ Million)
Table 107. GlaxoSmithKline Consumer Healthcare Corporation Information
Table 108. GlaxoSmithKline Consumer Healthcare Description and Major Businesses
Table 109. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. GlaxoSmithKline Consumer Healthcare Recent Developments
Table 112. Bayer Corporation Corporation Information
Table 113. Bayer Corporation Description and Major Businesses
Table 114. Bayer Corporation Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Bayer Corporation Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bayer Corporation Recent Developments
Table 117. Atnahs Pharma Corporation Information
Table 118. Atnahs Pharma Description and Major Businesses
Table 119. Atnahs Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Atnahs Pharma Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Atnahs Pharma Recent Developments
Table 122. Baudax Bio Corporation Information
Table 123. Baudax Bio Description and Major Businesses
Table 124. Baudax Bio Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Baudax Bio Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Baudax Bio Recent Developments
Table 127. Prestige Brands, Inc. Corporation Information
Table 128. Prestige Brands, Inc. Description and Major Businesses
Table 129. Prestige Brands, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Prestige Brands, Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Prestige Brands, Inc. Recent Developments
Table 132. Cumberland Pharmaceuticals, Inc. Corporation Information
Table 133. Cumberland Pharmaceuticals, Inc. Description and Major Businesses
Table 134. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Cumberland Pharmaceuticals, Inc. Recent Developments
Table 137. Takeda Pharmaceutical Company Corporation Information
Table 138. Takeda Pharmaceutical Company Description and Major Businesses
Table 139. Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Takeda Pharmaceutical Company Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Takeda Pharmaceutical Company Recent Developments
Table 142. Pfizer Inc. Corporation Information
Table 143. Pfizer Inc. Description and Major Businesses
Table 144. Pfizer Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Pfizer Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Pfizer Inc. Recent Developments
Table 147. McNeil Consumer Healthcare Corporation Information
Table 148. McNeil Consumer Healthcare Description and Major Businesses
Table 149. McNeil Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. McNeil Consumer Healthcare Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. McNeil Consumer Healthcare Recent Developments
Table 152. Eli Lilly and Company Corporation Information
Table 153. Eli Lilly and Company Description and Major Businesses
Table 154. Eli Lilly and Company Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Eli Lilly and Company Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Eli Lilly and Company Recent Developments
Table 157. Sun Pharmaceutical Industries Corporation Information
Table 158. Sun Pharmaceutical Industries Description and Major Businesses
Table 159. Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Sun Pharmaceutical Industries Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Sun Pharmaceutical Industries Recent Developments
Table 162. Validus Pharmaceuticals Corporation Information
Table 163. Validus Pharmaceuticals Description and Major Businesses
Table 164. Validus Pharmaceuticals Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Validus Pharmaceuticals Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Validus Pharmaceuticals Recent Developments
Table 167. Novartis Consumer Health Corporation Information
Table 168. Novartis Consumer Health Description and Major Businesses
Table 169. Novartis Consumer Health Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Novartis Consumer Health Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Novartis Consumer Health Recent Developments
Table 172. Pacira Pharmaceuticals, Inc. Corporation Information
Table 173. Pacira Pharmaceuticals, Inc. Description and Major Businesses
Table 174. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Pacira Pharmaceuticals, Inc. Recent Developments
Table 177. Almatica Pharma Corporation Information
Table 178. Almatica Pharma Description and Major Businesses
Table 179. Almatica Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 180. Almatica Pharma Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Almatica Pharma Recent Developments
Table 182. Actavis Corporation Information
Table 183. Actavis Description and Major Businesses
Table 184. Actavis Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 185. Actavis Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Actavis Recent Developments
Table 187. Arbor Pharmaceuticals, LLC Corporation Information
Table 188. Arbor Pharmaceuticals, LLC Description and Major Businesses
Table 189. Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 190. Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Arbor Pharmaceuticals, LLC Recent Developments
Table 192. PLx Pharma Inc. Corporation Information
Table 193. PLx Pharma Inc. Description and Major Businesses
Table 194. PLx Pharma Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 195. PLx Pharma Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. PLx Pharma Inc. Recent Developments
Table 197. Heron Therapeutics Corporation Information
Table 198. Heron Therapeutics Description and Major Businesses
Table 199. Heron Therapeutics Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 200. Heron Therapeutics Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Heron Therapeutics Recent Developments
Table 202. Assertio Therapeutics, Inc. Corporation Information
Table 203. Assertio Therapeutics, Inc. Description and Major Businesses
Table 204. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 205. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Assertio Therapeutics, Inc. Recent Developments
Table 207. Zyla Life Sciences Corporation Information
Table 208. Zyla Life Sciences Description and Major Businesses
Table 209. Zyla Life Sciences Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 210. Zyla Life Sciences Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Zyla Life Sciences Recent Developments
Table 212. Jazz Pharmaceuticals plc Corporation Information
Table 213. Jazz Pharmaceuticals plc Description and Major Businesses
Table 214. Jazz Pharmaceuticals plc Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 215. Jazz Pharmaceuticals plc Nonnarcotic Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 216. Jazz Pharmaceuticals plc Recent Developments
Table 217. Key Raw Materials Lists
Table 218. Raw Materials Key Suppliers Lists
Table 219. Nonnarcotic Analgesics Distributors List
Table 220. Nonnarcotic Analgesics Customers List
Table 221. Nonnarcotic Analgesics Market Trends
Table 222. Nonnarcotic Analgesics Market Drivers
Table 223. Nonnarcotic Analgesics Market Challenges
Table 224. Nonnarcotic Analgesics Market Restraints
Table 225. Research Programs/Design for This Report
Table 226. Key Data Information from Secondary Sources
Table 227. Key Data Information from Primary Sources
List of Figures
Figure 1. Nonnarcotic Analgesics Product Picture
Figure 2. Global Nonnarcotic Analgesics Market Share by Type in 2021 & 2028
Figure 3. Salicylates Product Picture
Figure 4. Anilines Product Picture
Figure 5. Pyrazolones Product Picture
Figure 6. Other Organic Acids Product Picture
Figure 7. Global Nonnarcotic Analgesics Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Specialist Clinic
Figure 11. Other
Figure 12. Nonnarcotic Analgesics Report Years Considered
Figure 13. Global Nonnarcotic Analgesics Sales 2017-2028 (K Units)
Figure 14. Global Nonnarcotic Analgesics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Nonnarcotic Analgesics Revenue 2017-2028 (US$ Million)
Figure 16. Global Nonnarcotic Analgesics Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Nonnarcotic Analgesics Sales Market Share by Region (2017-2022)
Figure 18. Global Nonnarcotic Analgesics Sales Market Share by Region (2023-2028)
Figure 19. North America Nonnarcotic Analgesics Sales YoY (2017-2028) & (K Units)
Figure 20. North America Nonnarcotic Analgesics Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Nonnarcotic Analgesics Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Nonnarcotic Analgesics Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Nonnarcotic Analgesics Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Nonnarcotic Analgesics Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Nonnarcotic Analgesics Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Nonnarcotic Analgesics Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Nonnarcotic Analgesics Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Nonnarcotic Analgesics Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Nonnarcotic Analgesics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Nonnarcotic Analgesics in the World: Market Share by Nonnarcotic Analgesics Revenue in 2021
Figure 31. Global Nonnarcotic Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Nonnarcotic Analgesics Sales Market Share by Type (2017-2028)
Figure 33. Global Nonnarcotic Analgesics Revenue Market Share by Type (2017-2028)
Figure 34. Global Nonnarcotic Analgesics Sales Market Share by Application (2017-2028)
Figure 35. Global Nonnarcotic Analgesics Revenue Market Share by Application (2017-2028)
Figure 36. North America Nonnarcotic Analgesics Sales Market Share by Type (2017-2028)
Figure 37. North America Nonnarcotic Analgesics Revenue Market Share by Type (2017-2028)
Figure 38. North America Nonnarcotic Analgesics Sales Market Share by Application (2017-2028)
Figure 39. North America Nonnarcotic Analgesics Revenue Market Share by Application (2017-2028)
Figure 40. North America Nonnarcotic Analgesics Sales Share by Country (2017-2028)
Figure 41. North America Nonnarcotic Analgesics Revenue Share by Country (2017-2028)
Figure 42. United States Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Nonnarcotic Analgesics Sales Market Share by Type (2017-2028)
Figure 45. Europe Nonnarcotic Analgesics Revenue Market Share by Type (2017-2028)
Figure 46. Europe Nonnarcotic Analgesics Sales Market Share by Application (2017-2028)
Figure 47. Europe Nonnarcotic Analgesics Revenue Market Share by Application (2017-2028)
Figure 48. Europe Nonnarcotic Analgesics Sales Share by Country (2017-2028)
Figure 49. Europe Nonnarcotic Analgesics Revenue Share by Country (2017-2028)
Figure 50. Germany Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 51. France Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Nonnarcotic Analgesics Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Nonnarcotic Analgesics Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Nonnarcotic Analgesics Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Nonnarcotic Analgesics Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Nonnarcotic Analgesics Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Nonnarcotic Analgesics Revenue Share by Region (2017-2028)
Figure 61. China Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 64. India Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Nonnarcotic Analgesics Sales Market Share by Type (2017-2028)
Figure 71. Latin America Nonnarcotic Analgesics Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Nonnarcotic Analgesics Sales Market Share by Application (2017-2028)
Figure 73. Latin America Nonnarcotic Analgesics Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Nonnarcotic Analgesics Sales Share by Country (2017-2028)
Figure 75. Latin America Nonnarcotic Analgesics Revenue Share by Country (2017-2028)
Figure 76. Mexico Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 79. Colombia Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Nonnarcotic Analgesics Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Nonnarcotic Analgesics Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Nonnarcotic Analgesics Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Nonnarcotic Analgesics Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Nonnarcotic Analgesics Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Nonnarcotic Analgesics Revenue Share by Country (2017-2028)
Figure 86. Turkey Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Nonnarcotic Analgesics Revenue (2017-2028) & (US$ Million)
Figure 89. Nonnarcotic Analgesics Value Chain
Figure 90. Nonnarcotic Analgesics Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed